After 15 weeks of treatment, the mean serum 25-hydroxyvitamin D levels were significantly higher (26%) in the FOSAVANCE (70 mg/ 2800 IU) group (56 nmol/ l [23 ng/ ml]) than in the alendronate-only group (46 nmol/ l [18.2 ng/ ml]).